AU753972C - Low adenosine oligonucleotide, composition, kit and methods for obtaining oligonucleotide and for treatment of airway disease(s) - Google Patents

Low adenosine oligonucleotide, composition, kit and methods for obtaining oligonucleotide and for treatment of airway disease(s)

Info

Publication number
AU753972C
AU753972C AU71749/00A AU7174900A AU753972C AU 753972 C AU753972 C AU 753972C AU 71749/00 A AU71749/00 A AU 71749/00A AU 7174900 A AU7174900 A AU 7174900A AU 753972 C AU753972 C AU 753972C
Authority
AU
Australia
Prior art keywords
oligonucleotide
kit
treatment
composition
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU71749/00A
Other versions
AU7174900A (en
AU753972B2 (en
Inventor
W. James Metzger
Jonathan W. Nyce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East Carolina University
Original Assignee
University of North Carolina at Chapel Hill
East Carolina University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU60959/96A external-priority patent/AU726468B2/en
Application filed by University of North Carolina at Chapel Hill, East Carolina University filed Critical University of North Carolina at Chapel Hill
Priority to AU71749/00A priority Critical patent/AU753972C/en
Publication of AU7174900A publication Critical patent/AU7174900A/en
Priority to AU50710/02A priority patent/AU5071002A/en
Publication of AU753972B2 publication Critical patent/AU753972B2/en
Application granted granted Critical
Publication of AU753972C publication Critical patent/AU753972C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU71749/00A 1995-06-07 2000-11-22 Low adenosine oligonucleotide, composition, kit and methods for obtaining oligonucleotide and for treatment of airway disease(s) Ceased AU753972C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU71749/00A AU753972C (en) 1995-06-07 2000-11-22 Low adenosine oligonucleotide, composition, kit and methods for obtaining oligonucleotide and for treatment of airway disease(s)
AU50710/02A AU5071002A (en) 1995-06-07 2002-06-28 Low adenosine oligonucleotide, composition, kit & methods for obtaining oligonucleotide & for treatment of airway disease(s)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/474497 1995-06-07
AU60959/96A AU726468B2 (en) 1995-06-07 1996-06-06 Low adenosine oligonucleotide, composition, kit & methods for obtaining oligonucleotide & for treatment of airway disease(s)
AU71749/00A AU753972C (en) 1995-06-07 2000-11-22 Low adenosine oligonucleotide, composition, kit and methods for obtaining oligonucleotide and for treatment of airway disease(s)

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU60959/96A Division AU726468B2 (en) 1995-06-07 1996-06-06 Low adenosine oligonucleotide, composition, kit & methods for obtaining oligonucleotide & for treatment of airway disease(s)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU50710/02A Division AU5071002A (en) 1995-06-07 2002-06-28 Low adenosine oligonucleotide, composition, kit & methods for obtaining oligonucleotide & for treatment of airway disease(s)

Publications (3)

Publication Number Publication Date
AU7174900A AU7174900A (en) 2001-02-01
AU753972B2 AU753972B2 (en) 2002-10-31
AU753972C true AU753972C (en) 2005-01-20

Family

ID=34085101

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71749/00A Ceased AU753972C (en) 1995-06-07 2000-11-22 Low adenosine oligonucleotide, composition, kit and methods for obtaining oligonucleotide and for treatment of airway disease(s)

Country Status (1)

Country Link
AU (1) AU753972C (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726408B2 (en) * 1996-12-23 2000-11-09 Dow Chemical Company, The Palatable hydroxypropyl methylcellulose ether powder with specified particle size

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726408B2 (en) * 1996-12-23 2000-11-09 Dow Chemical Company, The Palatable hydroxypropyl methylcellulose ether powder with specified particle size

Also Published As

Publication number Publication date
AU7174900A (en) 2001-02-01
AU753972B2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU6273796A (en) Nucleotide analogues for topical treatment of proliferative disease of the skin
AU6952896A (en) Method for treatment of cancer and infectious diseases and compositions useful in same
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2658199A (en) Synthetic process for the preparation of oligonucleotides, nucleoside synthons used therein, and oligonucleotides prepared thereby
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
AU6872498A (en) Method and composition for skin treatment
AU6187198A (en) System for diagnosis and treatment of soft tissue lesions
AU2327599A (en) Compositions and methods for treating autoimmune diseases
AU5336499A (en) Composition and method of treating disease with extract of (musaceas)
ZA964928B (en) Oral formulations of S(+)-etodolac.
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU3596199A (en) Treatment of celiac disease
AU4316899A (en) Method, reagent and kit for genotyping of human papillomavirus
AU3118499A (en) Soft tissue reconstructor and method of use
AU3784999A (en) Methods for treatment of pain
AU2002246490A1 (en) Method of treating parkinson's disease
AU6243799A (en) Verification of human medical data
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
AU4946699A (en) Method of treating meniere's disease and corresponding apparatus
AU6300296A (en) Oligonucleotides specific for human papillomavirus
AU4150999A (en) Method and kit for early diagnosis of cancer
EP1374894A3 (en) Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
AU753972C (en) Low adenosine oligonucleotide, composition, kit and methods for obtaining oligonucleotide and for treatment of airway disease(s)
AUPN115095A0 (en) Analysis of and compositions and methods for the treatment of disease

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20021119

FGA Letters patent sealed or granted (standard patent)